Seeking Alpha

Impax Laboratories (IPXL) and GlaxoSmithKline (GSK) announce positive top-line results of a...

Impax Laboratories (IPXL) and GlaxoSmithKline (GSK) announce positive top-line results of a Parkinson's disease study, as the firms move forward with their applications to the FDA and European Union. Premarket: IPXL +8.9%, GSK +0.8%. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|